Comparative Analysis of SARIMA and Neural Network Model Performance in Forecasting AstraZeneca and Moderna Stock Trading Volume Post-COVID-19 Pandemic
International Journal of Business Forecasting and Marketing Intelligence · 2026 · 1 (1)
DOI: 10.1504/ijbfmi.2026.10077925 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Business Forecasting and Marketing Intelligence, 2026. Verfasst von Sayida Nafisa und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nafisa, S., Dermawan, D. Z., Nurhalisa, R., & Rahmi, A. (2026). Comparative Analysis of SARIMA and Neural Network Model Performance in Forecasting AstraZeneca and Moderna Stock Trading Volume Post-COVID-19 Pandemic. International Journal of Business Forecasting and Marketing Intelligence, 1(1). https://doi.org/10.1504/ijbfmi.2026.10077925
Vancouver
Nafisa S, Dermawan DZ, Nurhalisa R, Rahmi A. Comparative Analysis of SARIMA and Neural Network Model Performance in Forecasting AstraZeneca and Moderna Stock Trading Volume Post-COVID-19 Pandemic. International Journal of Business Forecasting and Marketing Intelligence. 2026;1(1). doi:10.1504/ijbfmi.2026.10077925
BibTeX
@article{Nafisa2026,
author = {Nafisa, Sayida and Dermawan, Debrina Zarqa and Nurhalisa, Risma and Rahmi, Aqilla},
title = {Comparative Analysis of SARIMA and Neural Network Model Performance in Forecasting AstraZeneca and Moderna Stock Trading Volume Post-COVID-19 Pandemic},
journal = {International Journal of Business Forecasting and Marketing Intelligence},
year = {2026},
volume = {1},
number = {1},
doi = {10.1504/ijbfmi.2026.10077925}
}
EUVIMED